ClinicalTrialsFinder

Complement 3 Glomerulopathy (C3G) Clinical Trials in Shangxi

1 recruitingShangxi, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Chinese Adults With Kidney Disease

Immunoglobulin A Nephropathy (IgAN)IC-MPGNComplement 3 Glomerulopathy (C3G)
ADARx Pharmaceuticals, Inc.30 enrolled10 locationsNCT07522099